Aldevron Revenue and Competitors
Estimated Revenue & Valuation
- Aldevron's estimated annual revenue is currently $15.8M per year.
- Aldevron received $Undisclosed in venture funding in January 2017.
- Aldevron's estimated revenue per employee is $155,000
Employee Data
- Aldevron has 102 Employees.
- Aldevron grew their employee count by -89% last year.
Aldevron's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief IP Counsel | Reveal Email/Phone |
2 | Executive Assistant to President & CFO | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | VP Manufacturing | Reveal Email/Phone |
5 | VP/GM mRNA Services | Reveal Email/Phone |
6 | VP, Program Management | Reveal Email/Phone |
7 | VP, Information Technology and Security | Reveal Email/Phone |
8 | EVP Human Resources | Reveal Email/Phone |
9 | VP, Client Services, DNA | Reveal Email/Phone |
10 | VP, Global Technical Operations | Reveal Email/Phone |
Aldevron Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.6M | 17 | 0% | N/A | N/A |
#2 | $1M | 13 | 8% | N/A | N/A |
#3 | $2.3M | 15 | -12% | N/A | N/A |
#4 | $15.8M | 102 | -89% | N/A | N/A |
#5 | $0.8M | 5 | 0% | N/A | N/A |
#6 | $4.8M | 31 | -3% | N/A | N/A |
What Is Aldevron?
Aldevron provides contract manufacturing and scientific services. We specialize in plasmid DNA, protein production, and antibody generation. PLASMID DNA PRODUCTION With the successful completion of over 50,000 projects, we have developed unsurpassed expertise in plasmid manufacturing. Using proprietary technology, Aldevron manufactures DNA for a wide range of research, preclinical, clinical, and diagnostic applications (1 mg to 100 g). PROTEIN PRODUCTION Aldevron offers a wide range of protein services including host cell optimization, expression screening, process development, contract production, enzyme and antibody assay design, and more. Proteins produced by Aldevron are used for a wide range of agriculture and biomedical applications from research grade to full cGMP. ANTIBODY GENERATION GENOVAC Antibody Technology supports all project types from reagent antibodies to diagnostic and therapeutic applications with high success rates. Based on many years of experience, our immunization technology has been developed to cater for all protein targets where other methods have failed (including e.g. GPCRs). Our custom antibodies have been validated in over 130 publications and patents for more than 500 clients worldwide. Additional services include antibody processing, production, labeling, characterization and sequencing.
keywords:Biotechnology,Healthcare,PharmaceuticalsN/A
Total Funding
102
Number of Employees
$15.8M
Revenue (est)
-89%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aldevron News
Aldevron; Kaneka Eurogentec; Cobra Biologics; VGXI; AGC Biologics; Waisman Biomanufacturing; PlasmidFactory; Nature Technology Corporation (NTC)...
Aldevron; Kaneka Eurogentec; Cobra Biologics; VGXI; AGC Biologics; Waisman Biomanufacturing; PlasmidFactory; Nature Technology Corporation (NTC)...
Headquartered in Fargo, North Dakota, Aldevron manufactures plasmid DNA, which is a material needed to synthesize mRNA therapies and vaccines,...
Aldevron hosted its first Breakthrough Symposium (BTS) in Fall 2018 with an exciting lineup of industry leaders presenting their research and how it affects the present, and the future, of finding solutions to the world's biggest health challenges. Our inaugural presentation for the Breakthroug ...
Major Participants of worldwide Global Viral Vectors and Plasmid DNA Manufacturing Market: Aldevron, Eurogentec, Richter-Helm, ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $14.9M | 103 | 5% | N/A |
#2 | $15.1M | 104 | -5% | N/A |
#3 | $26.3M | 107 | 4% | N/A |
#4 | $10.8M | 108 | 4% | N/A |
#5 | $7.5M | 108 | -1% | N/A |
Aldevron Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2017-01-25 | $Undisclosed | Undisclosed | TA Associates | Article |